Clinical trial to determine the hypouricaemic potential of Zizyphus jujuba kernel

dc.contributor.authorWin Aungen_US
dc.contributor.authorAye Kyawen_US
dc.contributor.authorMyo Lwinen_US
dc.contributor.authorKhin Pyone Kyien_US
dc.contributor.authorMyat Myat Ohn Khinen_US
dc.contributor.authorThan Sween_US
dc.date.accessioned2009-06-30T08:46:10Z
dc.date.available2009-06-30T08:46:10Z
dc.date.created1997-01-01en_US
dc.date.issued1997-01-01en_US
dc.description.abstractClinical trial to determine the therapeutic efficacy of a traditional herbal drug, Zizyphus jujuba kernel reputed for anti-gout action was carried out on 20 healthy volunteers. Using a cross-over design, the subjects were divided into two groups. Group I received standard hypouricaemic drug, allopurinol and Group II was administered Z. jujuba dernel for 14 days. after a wash-out period of another 7 days, the drugs were crossed over between the two groups in which Group I was administered Z. jujuba kernel and Group II was administered allopurinol for further 14 days again. Blood and urine samples of these subjects were taken at 5 days' intervals throughout the study period for determination of uric acid, creatinine and liver function tests. It was found that Z. jujuba shows no abnormalities on kidney and liver function tests. It also possesses neither hypouricaemic nor uricosuric actions.en_US
dc.identifier.citationWin Aung, Aye Kyaw, Myo Lwin, Khin Pyone Kyi, Myat Myat Ohn Khin, Than Swe. Clinical trial to determine the hypouricaemic potential of Zizyphus jujuba kernel. Myanmar Health Sciences Research Journal. 1997; 9(1): 10-14en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/126904
dc.subject.meshClinical Trialsen_US
dc.subject.meshUric Acid-urineen_US
dc.subject.meshMyanmaren_US
dc.titleClinical trial to determine the hypouricaemic potential of Zizyphus jujuba kernelen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: